Developer docs
API playgroundTry for free, no card

Search company profiles

Sperm Check

Full company profile

uuid000fyy7

Namestring
Sperm Check
Legal namestring
SpermCheck
Websiteurl
spermcheck.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

SpermCheck is a privately held consumer diagnostics company founded in 2012 and headquartered in Charlottesville, Virginia at the UVA Research Park, originally commercialized from ContraVac, a University of Virginia startup founded by Dr. John Herr. The company develops, manufactures, and sells FDA-cleared at-home lateral flow immunoassay test kits that detect the SP-10 sperm-specific protein to provide a sperm count indication in minutes, marketed under the SpermCheck® Fertility and SpermCheck® Vasectomy product lines with reported 98% accuracy.

The company operates a direct-to-consumer and omnichannel retail model. Its two core SKUs — the SpermCheck Fertility Home Sperm Test ($49 per unit) and the SpermCheck Vasectomy Home Follow-Up Test ($79 per 2-pack, with a subscription option offering up to 25% savings) — are sold via the company's e-commerce site and distributed through major US pharmacy chains (CVS, Walgreens, Rite Aid) alongside international retail in the UK, Canada, Australia/New Zealand, and China. Both tests are FDA-cleared, FSA/HSA eligible, and positioned as private, low-cost alternatives to clinical semen analysis.

SpermCheck serves two primary consumer segments: men and couples trying to conceive who want a preliminary at-home fertility screen, and post-vasectomy men monitoring sterility. The company has cumulatively sold over one million tests and reports more than 5,000 verified five-star reviews, supported by content marketing, TV media placements, and an affiliate/influencer program. Operational and manufacturing infrastructure is anchored through an affiliation with DDC (DNA Diagnostics Center), which appears as the parent/manufacturing entity on the company's website.

Short descriptiontext

SpermCheck is a privately held, FDA-cleared at-home diagnostics company selling lateral flow sperm count test kits (Fertility and Vasectomy SKUs) directly to consumers via e-commerce and major US pharmacy retail, serving men and couples evaluating fertility or post-vasectomy sterility.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCharlottesville, United States
HQ citystring
Charlottesville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
at-home fertility tests, sperm count testing, vasectomy follow-up, diagnostic test kits, male fertility screening
Industry2 codes
PRIMARYHLAHAOAF
Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
At-Home Diagnostic Tests
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Direct Product Sales
TypeOne Time License
Description

SpermCheck generates revenue through one-time purchase of at-home sperm count test kits sold directly to consumers via e-commerce and retail pharmacies. The company also offers subscription plans with up to 25% savings for recurring purchases.

spermcheck.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D
Pricing details3 tiers
1SpermCheck Fertility Test - One-time purchase
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$49.00 per unit

spermcheck.com
2SpermCheck Vasectomy Test (2-Pack) - One-time purchase
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$79.00 for 2 tests

spermcheck.com
3SpermCheck Vasectomy Test - Subscription
ModelSubscriptionBilling cadenceMonthly
Notes

Subscribe and save up to 25%; $59.25 per 2-pack with subscription

spermcheck.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

SpermCheck sells FDA-cleared at-home sperm count test kits that detect SP-10 protein in semen samples to determine sperm count levels with 98% accuracy. The company offers two core products: the SpermCheck Fertility Home Sperm Test for men and couples trying to conceive, and the SpermCheck Vasectomy Home Follow-Up Test for post-vasectomy sterility confirmation. Both deliver results within minutes in the privacy of home without requiring a prescription or clinical visit.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 98% accuracy in detecting sperm count levels
+2 more records
Product overview1 text field

SpermCheck is the original at-home sperm count testing company offering two FDA-cleared diagnostic test kits: the SpermCheck® Fertility Home Sperm Test (for men checking fertility status when trying to conceive) and the SpermCheck Vasectomy Home Follow-Up Test (for men confirming sterility after vasectomy). Both tests are lateral flow immunoassay devices that detect SP-10 protein levels with 98% accuracy, providing results in minutes from the privacy of home. The company also offers subscription plans for the Vasectomy test with savings up to 25%.

Product and service2 records
1SpermCheck Fertility Home Sperm Test
CategoryAt-Home Fertility Diagnostic Test
Description

An FDA-cleared at-home sperm count test for men to check fertility status. Detects SP-10 protein levels with 98% accuracy and provides results within minutes for couples trying to conceive. Sold at $49 per unit.

2SpermCheck Vasectomy Home Follow-Up Test (2-Pack)
CategoryAt-Home Post-Vasectomy Diagnostic Test
Description

An FDA-cleared at-home test kit for post-vasectomy men to confirm their semen is sperm-free. The 2-pack allows testing at two different intervals (recommended at 60 and 90 days post-procedure). Sold at $79 for 2 tests, with subscription option offering up to 25% savings.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2024-10-01
Description

DDC appears in the footer as the parent/parent company for SpermCheck, providing manufacturing and regulatory support for the diagnostic test products.

2CVS Pharmacy
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2014-10-01
Description

SpermCheck products are sold in CVS retail stores nationwide as part of major pharmacy chain distribution expansion starting October 2014.

spermcheck.com
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2014-10-01
Description

SpermCheck products became available at Walgreens as part of the 2014 pharmacy store expansion alongside CVS and RiteAid.

Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2014-08-01
Description

SpermCheck announced major expansion into Rite Aid stores nationwide in August 2014, making products available at over 4,600 locations.

Strategic tierMajorTypeOthersAnnounced on2013-10-01
Description

Health Canada cleared SpermCheck Fertility for over-the-counter sale in Canada in October 2013, enabling international market expansion.

6Sonia Ribas (Fertility Coach)
Strategic tierMinorTypeGTM or Marketing Partner
Description

Sonia Ribas, a certified fertility coach with degrees from ESADE Business School and HEC Paris, provides insights and content for SpermCheck marketing materials.

spermcheck.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

SpermCheck was developed by ContraVac, a UVA startup based at the UVA Research Park, with Dr. John Herr as founder. The company originated from university research.

8Center for Innovative Technology (CIT)
Strategic tierMinorTypeOthers
Description

Virginia-based CIT (now Virginia Innovation Partnership Corporation) supported the technology transfer and commercialization of the SpermCheck product.

spermcheck.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1First Response (Church & Dwight)
TypeBroad incumbent
Description

Category-leading OTC pregnancy and ovulation test brand owned by Church & Dwight. Shares the at-home rapid diagnostic retail channel with SpermCheck and represents the broader consumer fertility testing incumbent SpermCheck competes against for shelf space.

TypeBroad incumbent
Description

Global OTC pregnancy and ovulation testing brand (Procter & Gamble / Swiss Precision Diagnostics). Competes for the same at-home reproductive-health self-testing shopper across pharmacy shelves and DTC channels where SpermCheck is sold.

3Dadi
TypeDirect peer
Description

Men's fertility company providing at-home sperm collection and reporting kits with optional storage. Competes with SpermCheck for the at-home male fertility testing entry point, adding a storage/subscription layer.

TypeDirect peer
Description

UK-based direct-to-consumer male fertility testing company offering at-home sperm analysis kits with smartphone-based video readouts and a coaching layer. Competes head-to-head with SpermCheck in the UK and increasingly in the US for at-home sperm testing wallet share.

TypeDirect peer
Description

Direct competitor selling an FDA-cleared at-home sperm test that pairs a cassette with a smartphone app to assess motility and count. Closest like-for-like rival to SpermCheck's at-home male fertility proposition, differentiated by digital video readouts.

TypeDirect peer
Description

Men's fertility company offering at-home sperm analysis and cryopreservation. Shares SpermCheck's at-home self-collection screening step before any clinical handoff, competing for the same male-factor-infertility aware consumer.

TypeBroad incumbent
Description

National clinical laboratory network that performs physician-ordered semen analysis, the $100–$1,000+ clinical alternative SpermCheck explicitly undercuts. Represents both a competitive incumbent and a potential channel/referral partner.

TypeBroad incumbent
Description

Large US clinical lab offering physician-ordered semen analysis and male fertility panels. Like Labcorp, sets the price-and-process benchmark that SpermCheck positions against for at-home pre-screening.

TypeDirect peer
Description

Sandstone Diagnostics spinoff (formerly known as Sandstone) selling at-home male fertility and testosterone test kits. Overlaps directly with SpermCheck's at-home diagnostics value proposition and distribution model.

TypeDirect peer
Description

UK-based men's fertility platform offering at-home sperm testing with clinical-grade analysis and fertility specialist access. Comparable to SpermCheck's at-home offering, with a stronger digital coaching and clinical referral layer.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sperm Check

At-Home Diagnostic Testsspermcheck.com

SpermCheck is a privately held, FDA-cleared at-home diagnostics company selling lateral flow sperm count test kits (Fertility and Vasectomy SKUs) directly to consumers via e-commerce and major US pharmacy retail, serving men and couples evaluating fertility or post-vasectomy sterility.

What Sperm Check does

SpermCheck is a privately held consumer diagnostics company founded in 2012 and headquartered in Charlottesville, Virginia at the UVA Research Park, originally commercialized from ContraVac, a University of Virginia startup founded by Dr. John Herr. The company develops, manufactures, and sells FDA-cleared at-home lateral flow immunoassay test kits that detect the SP-10 sperm-specific protein to provide a sperm count indication in minutes, marketed under the SpermCheck® Fertility and SpermCheck® Vasectomy product lines with reported 98% accuracy.

The company operates a direct-to-consumer and omnichannel retail model. Its two core SKUs — the SpermCheck Fertility Home Sperm Test ($49 per unit) and the SpermCheck Vasectomy Home Follow-Up Test ($79 per 2-pack, with a subscription option offering up to 25% savings) — are sold via the company's e-commerce site and distributed through major US pharmacy chains (CVS, Walgreens, Rite Aid) alongside international retail in the UK, Canada, Australia/New Zealand, and China. Both tests are FDA-cleared, FSA/HSA eligible, and positioned as private, low-cost alternatives to clinical semen analysis.

SpermCheck serves two primary consumer segments: men and couples trying to conceive who want a preliminary at-home fertility screen, and post-vasectomy men monitoring sterility. The company has cumulatively sold over one million tests and reports more than 5,000 verified five-star reviews, supported by content marketing, TV media placements, and an affiliate/influencer program. Operational and manufacturing infrastructure is anchored through an affiliation with DDC (DNA Diagnostics Center), which appears as the parent/manufacturing entity on the company's website.

Sperm Check firmographics

Firmographics
Name
Sperm Check
Legal name
SpermCheck
Website
https://spermcheck.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
1–10 employees
Short description
SpermCheck is a privately held, FDA-cleared at-home diagnostics company selling lateral flow sperm count test kits (Fertility and Vasectomy SKUs) directly to consumers via e-commerce and major US pharmacy retail, serving men and couples evaluating fertility or post-vasectomy sterility.
Ownership category
akta.pro rank

Sperm Check industry classification

Industry
Product category
At-Home Diagnostic Tests
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAOAF
Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)

Keywords

  • At-home fertility tests
  • Sperm count testing
  • Vasectomy follow-up
  • Diagnostic test kits
  • Male fertility screening

Where Sperm Check is headquartered

Location

Headquarters

HQ city
Charlottesville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Sperm Check business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D

Revenue model

  1. Direct Product Sales: SpermCheck generates revenue through one-time purchase of at-home sperm count test kits sold directly to consumers via e-commerce and retail pharmacies. The company also offers subscription plans with up to 25% savings for recurring purchases.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goSpermCheck Fertility Test - One-time purchase
One time/ perpetual licensePay-as-you-goSpermCheck Vasectomy Test (2-Pack) - One-time purchase
SubscriptionMonthlySpermCheck Vasectomy Test - Subscription

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Sperm Check product offering

Product offering

Core offering

SpermCheck sells FDA-cleared at-home sperm count test kits that detect SP-10 protein in semen samples to determine sperm count levels with 98% accuracy. The company offers two core products: the SpermCheck Fertility Home Sperm Test for men and couples trying to conceive, and the SpermCheck Vasectomy Home Follow-Up Test for post-vasectomy sterility confirmation. Both deliver results within minutes in the privacy of home without requiring a prescription or clinical visit.

Product overview

SpermCheck is the original at-home sperm count testing company offering two FDA-cleared diagnostic test kits: the SpermCheck® Fertility Home Sperm Test (for men checking fertility status when trying to conceive) and the SpermCheck Vasectomy Home Follow-Up Test (for men confirming sterility after vasectomy). Both tests are lateral flow immunoassay devices that detect SP-10 protein levels with 98% accuracy, providing results in minutes from the privacy of home. The company also offers subscription plans for the Vasectomy test with savings up to 25%.

Differentiator

Problem solved

Functional benefit

Products and services

  • SpermCheck Fertility Home Sperm Test An FDA-cleared at-home sperm count test for men to check fertility status. Detects SP-10 protein levels with 98% accuracy and provides results within minutes for couples trying to conceive. Sold at $49 per unit.
  • SpermCheck Vasectomy Home Follow-Up Test (2-Pack) An FDA-cleared at-home test kit for post-vasectomy men to confirm their semen is sperm-free. The 2-pack allows testing at two different intervals (recommended at 60 and 90 days post-procedure). Sold at $79 for 2 tests, with subscription option offering up to 25% savings.

Quantifiable outcome

  • 98% accuracy in detecting sperm count levels
  • +2 more outcomes

Companies that use Sperm Check

Customer profile

Segments3 records

Ideal customer profiles3 records

Sperm Check technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Sperm Check partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core, major and minor.

  • DDC (Diagnostic Testing Corporation)coreOEM/ Whitelabel/ Licensing Partner · 1 October 2024DDC appears in the footer as the parent/parent company for SpermCheck, providing manufacturing and regulatory support for the diagnostic test products.
  • CVS PharmacymajorChannel Partner/ Reseller/ Distributor · 1 October 2014SpermCheck products are sold in CVS retail stores nationwide as part of major pharmacy chain distribution expansion starting October 2014.
  • WalgreensmajorChannel Partner/ Reseller/ Distributor · 1 October 2014SpermCheck products became available at Walgreens as part of the 2014 pharmacy store expansion alongside CVS and RiteAid.
  • Rite AidmajorChannel Partner/ Reseller/ Distributor · 1 August 2014SpermCheck announced major expansion into Rite Aid stores nationwide in August 2014, making products available at over 4,600 locations.
  • Health CanadamajorOthers · 1 October 2013Health Canada cleared SpermCheck Fertility for over-the-counter sale in Canada in October 2013, enabling international market expansion.
  • Sonia Ribas (Fertility Coach)minorGTM or Marketing PartnerSonia Ribas, a certified fertility coach with degrees from ESADE Business School and HEC Paris, provides insights and content for SpermCheck marketing materials.
  • UVA Research Park / ContraVaccoreStrategic or Co-development PartnerSpermCheck was developed by ContraVac, a UVA startup based at the UVA Research Park, with Dr. John Herr as founder. The company originated from university research.
  • Center for Innovative Technology (CIT)minorOthersVirginia-based CIT (now Virginia Innovation Partnership Corporation) supported the technology transfer and commercialization of the SpermCheck product.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Sperm Check competitors and assessment

Company assessment

Broad incumbents

  • First Response (Church & Dwight): Category-leading OTC pregnancy and ovulation test brand owned by Church & Dwight. Shares the at-home rapid diagnostic retail channel with SpermCheck and represents the broader consumer fertility testing incumbent SpermCheck competes against for shelf space.
  • Clearblue: Global OTC pregnancy and ovulation testing brand (Procter & Gamble / Swiss Precision Diagnostics). Competes for the same at-home reproductive-health self-testing shopper across pharmacy shelves and DTC channels where SpermCheck is sold.
  • Labcorp: National clinical laboratory network that performs physician-ordered semen analysis, the $100–$1,000+ clinical alternative SpermCheck explicitly undercuts. Represents both a competitive incumbent and a potential channel/referral partner.
  • Quest Diagnostics: Large US clinical lab offering physician-ordered semen analysis and male fertility panels. Like Labcorp, sets the price-and-process benchmark that SpermCheck positions against for at-home pre-screening.

Direct peers

  • Dadi: Men's fertility company providing at-home sperm collection and reporting kits with optional storage. Competes with SpermCheck for the at-home male fertility testing entry point, adding a storage/subscription layer.
  • ExSeed Health: UK-based direct-to-consumer male fertility testing company offering at-home sperm analysis kits with smartphone-based video readouts and a coaching layer. Competes head-to-head with SpermCheck in the UK and increasingly in the US for at-home sperm testing wallet share.
  • YO Home Sperm Test (Medical Electronic Systems): Direct competitor selling an FDA-cleared at-home sperm test that pairs a cassette with a smartphone app to assess motility and count. Closest like-for-like rival to SpermCheck's at-home male fertility proposition, differentiated by digital video readouts.
  • Legacy: Men's fertility company offering at-home sperm analysis and cryopreservation. Shares SpermCheck's at-home self-collection screening step before any clinical handoff, competing for the same male-factor-infertility aware consumer.
  • Fellow Health: Sandstone Diagnostics spinoff (formerly known as Sandstone) selling at-home male fertility and testosterone test kits. Overlaps directly with SpermCheck's at-home diagnostics value proposition and distribution model.
  • Mojo: UK-based men's fertility platform offering at-home sperm testing with clinical-grade analysis and fertility specialist access. Comparable to SpermCheck's at-home offering, with a stronger digital coaching and clinical referral layer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Sperm Check social profiles

Digital presence

Sperm Check compliance and trust

Trust signal

Compliance1 record

Sperm Check financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sperm Check leadership team

Management profile

Number of profiles

Profiles1 record

Sperm Check funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sperm Check M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sperm Check

What does Sperm Check do?

SpermCheck sells FDA-cleared at-home sperm count test kits that detect SP-10 protein in semen samples to determine sperm count levels with 98% accuracy. The company offers two core products: the SpermCheck Fertility Home Sperm Test for men and couples trying to conceive, and the SpermCheck Vasectomy Home Follow-Up Test for post-vasectomy sterility confirmation. Both deliver results within minutes in the privacy of home without requiring a prescription or clinical visit.

Is Sperm Check a public or private company?

Sperm Check is a private company. It is classified as corporate owned and is currently operating.

When was Sperm Check founded?

Sperm Check was founded in 2012. It employs 1 to 10 people.

Where is Sperm Check based?

Sperm Check is headquartered in Charlottesville, United States, in the North America region.

How does Sperm Check make money?

One revenue line is on record: direct Product Sales.

Who are Sperm Check's main competitors?

Broad incumbents on record are First Response (Church & Dwight), Clearblue, Labcorp and Quest Diagnostics. Direct peers are Dadi, ExSeed Health, YO Home Sperm Test (Medical Electronic Systems), Legacy, Fellow Health and Mojo.

Does Sperm Check have an API?

No public API is recorded for Sperm Check.

What industry is Sperm Check in?

Sperm Check's product category is At-Home Diagnostic Tests. Its primary akta.pro industry code is HLAHAOAF, Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection), with a secondary code of HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals